Systematic review of studies on rotavirus disease cost-of-illness and productivity loss in Latin America and the Caribbean

被引:8
|
作者
Soligo Takemoto, Maira Libertad [1 ]
Bahia, Luciana [1 ]
Toscano, Cristiana M. [2 ]
Araujo, Denizar Vianna [1 ]
机构
[1] Univ Estado Rio De Janeiro, BR-20551030 Rio De Janeiro, RJ, Brazil
[2] Univ Fed Goias, Goiania, Go, Brazil
关键词
Rotavirus; Cost of illness; Systematic review; Latin America and Caribbean; ECONOMIC-IMPACT; DIARRHEAL DISEASE; MEXICAN CHILDREN; GLOBAL PROBLEM; VACCINATION; GASTROENTERITIS; MORTALITY; HEALTH; MAGNITUDE; COUNTRIES;
D O I
10.1016/j.vaccine.2013.05.031
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Rotavirus is the most common cause of severe acute diarrhea among children in both developed and developing countries. Vaccination can reduce the disease burden and its incorporation into health care systems should consider future costs and benefits. Objectives: To systematically review studies on costs due to rotavirus infection in Latin America and Caribbean (LAC) region, considering their methods and results. Methods: A search of relevant databases including the Cochrane Central Register of Controlled Trials, Embase, MEDLINE via PubMed, the Latin American and Caribbean Health Sciences Literature database (LILACS), and the Brazilian Thesis Databank was performed. Inclusion criteria for studies were: (a) economic evaluation or cost-of-illness studies; (b) conducted in the LAC region; (c) assess economic burden of rotavirus disease or the economic impact of rotavirus vaccination programs. Two authors independently screened the studies for eligibility. Results: Of 444 studies initially retrieved, 21 met the eligibility criteria and were included (14 cost-effectiveness analyses of vaccination programs and 7 cost-of-illness studies). Direct medical costs were assessed in all 21 studies, but only 10 also investigated indirect and non-medical direct costs. The most commonly observed methods for cost estimation were retrospective database analysis and hospital-based surveillance study. Only one study was a household-based survey. A wide cost range was identified (e.g., inpatient care US$79.91 to US$858.40 and outpatient care US$13.06 to US$64.10), depending on the methods, study perspective, and type of costs included. Conclusion: Rotavirus-associated costs were assessed in 21 studies across the Latin America and Caribbean region. The majority of studies were made alongside economic evaluations of vaccination programs. Methods are broadly different among studies but administrative databases seem to be the most employed source of data. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:C45 / C57
页数:13
相关论文
共 50 条
  • [21] The financial burden of psychosocial workplace aggression: A systematic review of cost-of-illness studies
    Hassard, Juliet
    Teoh, Kevin R. H.
    Visockaite, Gintare
    Dewe, Philip
    Cox, Tom
    WORK AND STRESS, 2018, 32 (01) : 6 - 32
  • [22] Productivity Loss in Patients With Chronic Diseases: A Pooled Economic Analysis of Hungarian Cost-of-Illness Studies
    Rashdan, Omar
    Brodszky, Valentin
    VALUE IN HEALTH REGIONAL ISSUES, 2020, 22 : 75 - 82
  • [23] Cost-of-illness studies in heart failure: a systematic review 2004-2016
    Lesyuk, Wladimir
    Kriza, Christine
    Kolominsky-Rabas, Peter
    BMC CARDIOVASCULAR DISORDERS, 2018, 18
  • [24] Socio-economic costs of osteoarthritis: A systematic review of cost-of-illness studies
    Puig-Junoy, Jaume
    Ruiz, Alba
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2015, 44 (05) : 531 - 541
  • [25] Cost-of-illness studies in rare diseases: a scoping review
    Lidia García-Pérez
    Renata Linertová
    Cristina Valcárcel-Nazco
    Manuel Posada
    Inigo Gorostiza
    Pedro Serrano-Aguilar
    Orphanet Journal of Rare Diseases, 16
  • [26] A review of caregiver costs included in cost-of-illness studies
    Mattingly, T. Joseph, II
    Diaz Fernandez, Valeria
    Seo, Dominique
    Melgar Castillo, Andrea I.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2022, 22 (07) : 1051 - 1060
  • [27] Cost-of-illness studies in rare diseases: a scoping review
    Garcia-Perez, Lidia
    Linertova, Renata
    Valcarcel-Nazco, Cristina
    Posada, Manuel
    Gorostiza, Inigo
    Serrano-Aguilar, Pedro
    ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
  • [28] Intersectoral costs of sexually transmitted infections (STIs) and HIV: a systematic review of cost-of-illness (COI) studies
    Schnitzler, Lena
    Jackson, Louise J.
    Paulus, Aggie T. G.
    Roberts, Tracy E.
    Evers, Silvia M. A. A.
    BMC HEALTH SERVICES RESEARCH, 2021, 21 (01)
  • [29] Social capital and health in Latin America and the Caribbean: a systematic review
    Kripper, Cristobal E.
    Sapag, Jaime C.
    REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH, 2009, 25 (02): : 162 - 170
  • [30] The economic costs of loneliness: a review of cost-of-illness and economic evaluation studies
    Mihalopoulos, Cathrine
    Le, Long Khanh-Dao
    Chatterton, Mary Lou
    Bucholc, Jessica
    Holt-Lunstad, Julianne
    Lim, Michelle H.
    Engel, Lidia
    SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 2020, 55 (07) : 823 - 836